- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.02. | Madrigal turns to RNAi drugs from China to bolster MASH pipeline | ||
| 11.02. | Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill | ||
| 11.02. | FDA refuses to review Moderna's mRNA flu vaccine | ||
| 10.02. | Nektar, continuing comeback, says eczema drug's effects hold up in follow-up study | ||
| 10.02. | FDA rejects Regenxbio treatment in another blow to gene therapy | ||
| 09.02. | Lilly buys 'in vivo' CAR-T maker Orna, extending streak of genetic medicine deals | ||
| 09.02. | Lilly bets again on China drugs; Roche showcases MS data | ||
| 09.02. | Takeda, Iambic partner in latest pharma AI push | ||
| 09.02. | Navigating the complexities of Cell and Gene Therapy supply chains | ||
| 09.02. | Small and mighty: single-domain antibodies pack a biological punch | ||
| 06.02. | White House's online service for drug sales debuts with limited impact on prices | ||
| 06.02. | Agomab, SpyGlass Pharma bank a combined $350M in biotech IPOs | ||
| 05.02. | Earnings roundup: AbbVie angst, a bifurcated vaccine market and Bristol Myers' waiting game | ||
| 05.02. | Novo, Lilly sputter as Hims launches knockoff GLP-1 pill | ||
| 05.02. | Bayer details anticipated stroke prevention data for new blood-thinner | ||
| 05.02. | Generate, an AI-driven Flagship startup, pitches an IPO | ||
| 05.02. | Express Scripts reaches 'landmark' settlement with FTC in insulin suit | ||
| 05.02. | Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings | ||
| 04.02. | Trump signs funding bill with PBM reforms, hospital-at-home and telehealth extensions | ||
| 04.02. | Novo shares tumble by double digits on grim sales outlook | ||
| 04.02. | Lilly soars again as fast-selling weight loss drugs top Wall Street projections | ||
| 04.02. | Earnings roundup: Amgen vs. FDA, Pfizer's defense and Merck's $70B-in-sales plan | ||
| 03.02. | Pfizer dips on new data for obesity drug acquired in $10B deal | ||
| 03.02. | FDA launches 'PreCheck' program; AstraZeneca, Acadia drugs set back | ||
| 02.02. | Novo combination obesity shot meets goal in diabetes trial |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.